Overview

Inhibition of Sterile Inflammation by Digoxin

Status:
Recruiting

Trial end date:
2023-07-28

Target enrollment:

Participant gender:

Summary

To investigate the effect of digoxin on pyruvate kinase isoform 2 (PKM2) binding to pro-inflammatory loci and innate immune inflammatory responses in the peripheral blood in healthy subjects.

Phase:

Phase 1

Details

Lead Sponsor:

Yale University

Treatments:

Digoxin